Extended Platelet Rich Fibrin or Hyaluronate Enriched Xenografts for Horizontal Ridge Augmentation Via Subperiosteal Tunneling (E-PRF)

Mansoura University

Status: Completed

Conditions: Dental Implant

Treatments: Combination Product: bovine bone mixed with hyaluronate; Combination Product: bovine bone mixed with E-PEF

Study type: Interventional

Funder types: Other

Identifiers

NCT07412535

R.25.12.94

Details and patient eligibility

About

Extended platelet rich fibrin or hyaluronate enriched xenografts will be used for horizontal maxillary ridge augmentation via subperiosteal tunneling to allow placement of dental implants six months later.

Enrollment: 34 patients

Sex: All

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• a maxillary anterior or premolar narrow ridge (width 3-6 mm), and adequate bone height (>8 mm), seeking horizontal augmentation & dental implant rehabilitation

Exclusion criteria

• systemic contraindications to surgery, local infection, untreated periodontal disease, heavy smoking, or pregnancy.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

34 participants in 2 patient groups

Hyaluronate Group

Active Comparator group

Description:

Horizontal maxillary augmentation via subperiosteal tunneling using bovine bone and hyaluronate

Treatment:

Combination Product: bovine bone mixed with hyaluronate

Extended Platelet Rich Fibrin Group

Experimental group

Description:

horizontal maxillary augmentation via subperiosteal tunneling using bovine bone and extended platelet rich fibrin

Treatment:

Combination Product: bovine bone mixed with E-PEF